• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Scientific Publications by FDA Staff

  • Print
  • Share
  • E-mail
-

Search Publications



Fields



Centers











Starting Date


Ending Date


Order by

Entry Details

CrystEngComm 2014 Jul 21;16(27):6244-9

In situ fabrication of Cu2ZnSnS4 nanoflake thin films on both rigid and flexible substrates.

Zhai XZ, Jia HM, Zhang YE, Lei Y, Wei J, Gao YH, Chu JH, He WW, Yin JJ, Zheng Z

Abstract

Cu2ZnSnS4 (CZTS) thin film, a highly promising and low-cost absorber layer material for solar cells, has been in situ fabricated on stainless steel and FTO glass substrates for the first time, using a one-step solvothermal treatment of CuZnSn-alloyed film with sulphur or selenium powder. The resulting products were characterized by X-ray diffractometry (XRD), scanning electron microscopy (SEM), transmission electron microscopy (TEM), and UV-vis-NIR spectroscopy. Raman spectroscopy was used to characterize and confirm the formation of CZTS. The effects of temperature, reaction time, the ratio of Cu/Zn/Sn, and non-elemental reactants on the formation of CZTS nanocrystal films were assessed, and we found that the reaction temperature was a key factor in determining the properties of the final products. Pure CZTS phase forms at a temperature of 250 degrees C or higher. Our method produces CZTS thin films at 250 degrees C, the lowest reaction temperature that can be used in the process and the lowest temperature of any current fabrication system. We also found that flexible substrates promote the growth of CZTS nanocrystals. Using flexible substrates in the in situ fabrication of nanocrystalline thin films may make it possible to use CZTS for industrial applications.


Category: Journal Article
DOI: 10.1039/c4ce00174e
Includes FDA Authors from Scientific Area(s): Food
Entry Created: 2014-08-02 Entry Last Modified: 2018-09-23
Feedback
-
-